We are live on ! Find out more
ONXX

ONYX PHARMACEUTICALS INC
ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

Back to rankings

258 hedge funds and large institutions have $7.38B invested in ONYX PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 54 increasing their positions, 104 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more funds holding in top 10

Funds holding in top 10: 12 → 46 (+34)

55% more call options, than puts

Call options by funds: $1.26B | Put options by funds: $810M

5% less funds holding

Funds holding: 272 → 258 (-14)

13% less first-time investments, than exits

New positions opened: 83 | Existing positions closed: 95

20% less capital invested

Capital invested by funds: $9.18B → $7.38B (-$1.8B)

48% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 104

Holders
258
Holders Change
-14
Holders Change %
-5.15%
% of All Funds
8.36%
Holding in Top 10
46
Holding in Top 10 Change
+34
Holding in Top 10 Change %
+283.33%
% of All Funds
1.49%
New
83
Increased
54
Reduced
104
Closed
95
Calls
$1.26B
Puts
$810M
Net Calls
+$448M
Net Calls Change
+$468M

Top Buyers

Rank Fund Capital Flow
1
DKCM
Davidson Kempner Capital Management
New York
+$399M
2
HI
HBK Investments
Texas
+$344M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$336M
4
ACPU
Arrowgrass Capital Partners (US)
Delaware
+$250M
5
FCM
Farallon Capital Management
California
+$248M

Top Sellers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$1.39B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.22B
3
JP Morgan Chase
JP Morgan Chase
New York
-$736M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$580M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$331M
Name Holding Trade Value Shares
Change 		Change in
Stake
Schroder Investment Management Group
276
Schroder Investment Management Group
United Kingdom
– -$20.5M -236,500 Closed
NFA
277
Nationwide Fund Advisors
Ohio
– -$18.6M -213,980 Closed
N
278
Nuveen
North Carolina
– -$16.2M -186,997 Closed
CS
279
Credit Suisse
Switzerland
– -$16.1M -186,012 Closed
BLM
280
Bennett Lawrence Management
New York
– -$15.5M -178,580 Closed
Mackenzie Financial
281
Mackenzie Financial
Ontario, Canada
– -$11.4M -131,200 Closed
FWIA
282
Fort Washington Investment Advisors
Ohio
– -$11.1M -128,376 Closed
PCM
283
Palisade Capital Management
New Jersey
– -$9.68M -111,511 Closed
PCM
284
Penn Capital Management
Pennsylvania
– -$7.97M -91,798 Closed
Balyasny Asset Management
285
Balyasny Asset Management
Illinois
– -$7.2M -82,900 Closed
AAMU
286
Amundi Asset Management US
Massachusetts
– -$6.88M -79,300 Closed
DIA
287
Denver Investment Advisors
Colorado
– -$6.71M -77,260 Closed
Charles Schwab
288
Charles Schwab
California
– -$9.36M -71,277 Closed
STC
289
SEI Trust Company
Pennsylvania
– -$5.33M -61,350 Closed
PI
290
Putnam Investments
Massachusetts
– -$4.96M -57,100 Closed
First Trust Advisors
291
First Trust Advisors
Illinois
– -$4.12M -47,393 Closed
KCM
292
Kingdon Capital Management
New York
– -$3.65M -42,100 Closed
VOYA Investment Management
293
VOYA Investment Management
Georgia
– -$3.59M -41,400 Closed
SONJCPFA
294
State of New Jersey Common Pension Fund A
New Jersey
– -$3.47M -40,000 Closed
WMSA
295
Weiss Multi-Strategy Advisers
New York
– -$3.04M -35,000 Closed
NIP
296
Nicholas Investment Partners
California
– -$3M -34,563 Closed
PA
297
Profund Advisors
Maryland
– -$2.9M -33,428 Closed
Los Angeles Capital Management
298
Los Angeles Capital Management
California
– -$2.78M -32,000 Closed
SCM
299
Sigma Capital Management
Connecticut
– -$3.27M -30,000 Closed
RJA
300
Raymond James & Associates
Florida
– -$2.41M -27,749 Closed
10 11
12
13 14

ONXX Hedge Fund Activity: Q3 2013 in Review

258 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q3 2013, worth a combined $7.38B — down 20% from $9.18B a quarter earlier.

Sellers outnumbered buyers: 95 funds closed out of ONXX and 83 opened new positions — a net loss of 12 holders — while 104 trimmed existing stakes and 54 added.

The largest buyer was Davidson Kempner Capital Management, opening a new position worth an estimated $399M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $1.39B.

  • 258 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q3 2013, down from 272 in Q2 2013.
  • Funds reported $7.38B of ONYX PHARMACEUTICALS INC stock for Q3 2013, down 20% quarter-over-quarter.
  • 83 funds opened new ONYX PHARMACEUTICALS INC positions in Q3 2013 and 95 closed out, a net change of -12 holders.
  • The largest ONYX PHARMACEUTICALS INC buyer in Q3 2013 was Davidson Kempner Capital Management, an estimated $399M added.
  • The largest ONYX PHARMACEUTICALS INC seller in Q3 2013 was BNP Paribas Financial Markets, an estimated $1.39B sold.

Based on aggregated 13F filings for Q3 2013.